Anteilseigner
Syncona Investment Management Ltd. (26,98 %) Forbion Capital Partners Management Holding BV (5,82 %) Redmile Group LLC (3,91 %) Vestal Point Capital LP (3,65 %) OrbiMed Advisors Private Equity (3,56 %) Ikarian Capital LLC (3,51 %) StemPoint Capital LP (3,37 %) Baker Bros. Advisors LP (2,94 %) Renaissance Technologies LLC (2,45 %) Invus Public Equities Advisors LLC (1,84 %) Boothbay Fund Management LLC (1,02 %) Acadian Asset Management LLC (0,68 %) Citadel Securities LLC (0,26 %) HRT Financial LLC (0,09 %) Geode Capital Management LLC (0,05 %) Virtu Americas LLC (0,05 %) Millennium Management LLC (0,05 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,04 %)
Kontakt
Achilles Therapeutics PLC